PNI Digital Media Inc. selects R&D Logic software and services.
October 2012 — PNIDigitalMedia, located in Vancouver, Canada has subscribed to R&D Logic software and services for managing planning, tracking, consolidation reporting as well as time collection. At its core, PNI Digital Media provides a proprietary transactional software platform that is used by leading retailers such as Costco, Walmart Canada, and CVS/pharmacy to sell millions of personalized products every year.
Solazyme selects R&D Time software and services.
October 2012 — Solazyme, located in South San Francisco, California has subscribed to R&D Logic software and services as the corporate-wide solution for collecting, managing and reporting project effort, FTEs as well as time off. Solazyme has pioneered an industrial biotechnology platform that harnesses the prolific oil-producing ability of microalgae.
Pfenex, Inc. selects R&D Logic software platform and services.
September 2012 — Pfenex, located in San Diego, California, has subscribed to R&D Logic software and services for managing planning, tracking, analysis and consolidation reporting. Pfenex is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.
EnVivo Pharmaceuticals, Inc. subscribes to R&D Logic software and services.
August 2012 — EnVivo, located in Watertown, Massachusetts, has subscribed to R&D Logic software and services for managing FP&A corporate processes. EnVivo is developing its broad pipeline of diverse programs with a focus on leveraging novel mechanisms of action to treat CNS diseases like schizophrenia and Alzheimer’s disease in new ways and from multiple angles.
Epizyme, Inc. selects R&D Logic Plaform for the Business of Science.
June 2012 — Epizyme, located in Cambridge, Massachusetts, has subscribed to R&D Logic software and services for planning, tracking, time collection and consolidated reporting of the R&D Portfolio and of Corporate Financials. Epizyme is leading the discovery and development of small molecule histone methyltransferase(HMT)inhibitors, a new class of personalized therapeutics for the treatment of patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics.
Aveo Pharmaceuticals, Inc. subscribes to R&D Logic Time Collection & Reporting software and services.
June 2012 — AVEO, located in Cambridge, Massachusetts, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. AVEO Oncology is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives.
R&D Logic introduces R&D GRANT to support planning and tracking grants from NIH, DARPA, SBIR, other government agencies or private foundations.
June 2012 — With R&D GRANT, customers can ensure that funds are fully drawn and that indirect costs are recovered.
OncoGenex Pharmaceuticals, Inc. selects R&D Logic Planning and Tracking Software.
January 2012 — OncoGenex, located in Vancouver, Canada and Seattle, Washington, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.